Passage Bio
0 followers
PASG
Performance
About Passage Bio
Passage Bio is a biotech company focused on developing genetic medicines to treat central nervous system disorders. The company is advancing lead programs in neurodegenerative diseases, including gene therapies for frontotemporal dementia due to progranulin mutations. With multinational clinical studies, Passage Bio aims to transform patient lives in the United States and globally by addressing underlying genetic causes of CNS conditions.
Recent News
No recent news for this company.